Literature DB >> 15611431

Response of oral lichen planus to topical tacrolimus in 37 patients.

Julie A Byrd1, Mark D P Davis, Alison J Bruce, Lisa A Drage, Roy S Rogers.   

Abstract

BACKGROUND: Topical tacrolimus has been reported to be effective for the treatment of oral lichen planus. This article describes our experience with topical tacrolimus in patients treated for symptomatic oral lichen planus. OBSERVATIONS: A survey was mailed to 40 patients with symptomatic oral lichen planus treated with topical tacrolimus. Surveys were completed by 37 patients (93%) a mean of 1.3 years after initiation of treatment. Thirty-three (89%) of the 37 patients reported symptomatic improvement, and 31 (84%) reported partial to complete lesion clearance while using topical tacrolimus. On average, patients noted improvement in 1 month. Twelve patients (32%) reported adverse effects consistent with those reported previously (ie, burning, irritation, and tingling). Among the 28 patients still using the medication, 15 patients (54%) apply it at least once daily. Of the 9 patients who discontinued using the medication, 5 experienced recurrence.
CONCLUSIONS: Topical tacrolimus is effective for the treatment of oral lichen planus. Most patients experienced symptomatic improvement in less than 1 month. However, the effect is temporary; when topical tacrolimus is discontinued, oral lichen planus may flare again.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15611431     DOI: 10.1001/archderm.140.12.1508

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  10 in total

1.  Levamisole monotherapy for oral lichen planus.

Authors:  Tai Hyok Won; Se Young Park; Bo Suk Kim; Phil Seung Seo; Seok Don Park
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

2.  Treatment of geographic tongue with topical tacrolimus.

Authors:  Jigar M Purani; Hiral J Purani
Journal:  BMJ Case Rep       Date:  2014-08-01

Review 3.  An active surveillance program in oral preneoplasia and translational oncology benefit.

Authors:  Hunter Archibald; Seth Buryska; Frank G Ondrey
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-07-21

4.  Treatment of symptomatic oral lichen planus (OLP) with 0.1% tacrolimus powder in Oraguard-B - A pilot prospective study.

Authors:  Upender Malik; Siddharth Gupta; Shilpa D Malik; Shirin Vashishth; M S Raju
Journal:  Saudi Dent J       Date:  2012-06-26

Review 5.  Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research.

Authors:  J W Mays; H Fassil; D A Edwards; S Z Pavletic; C W Bassim
Journal:  Oral Dis       Date:  2012-10-28       Impact factor: 3.511

6.  Oral lichen planus treated with tacrolimus 0.1%.

Authors:  João Paulo Marinho Resende; Maria das Graças Afonso Miranda Chaves; Fernando Monteiro Aarestrup; Beatriz Vieira Aarestrup; Sergio Olate; Henrique Duque Netto
Journal:  Int J Clin Exp Med       Date:  2013-10-25

7.  The comparison of efficacy of adcortyl ointment and topical tacrolimus in treatment of erosive oral lichen planus.

Authors:  Arash Azizi; Shirin Lawaf
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2007-12-20

8.  The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report.

Authors:  Jürgen C Becker; Roland Houben; Claudia S Vetter; Eva B Bröcker
Journal:  BMC Cancer       Date:  2006-01-11       Impact factor: 4.430

9.  Systemic tacrolimus in the treatment of recalcitrant mucosal lichen planus.

Authors:  Edward Chen; Naveed Sami
Journal:  JAAD Case Rep       Date:  2017-05-24

10.  A randomized triple-blind clinical trial to compare the effectiveness of topical triamcinolone acetonate (0.1%), clobetasol propionate (0.05%), and tacrolimus orabase (0.03%) in the management of oral lichen planus.

Authors:  Shivakumar Sivaraman; Krishnamoorthy Santham; Aruldoss Nelson; Bijaykumar Laliytha; Pandian Azhalvel; John Hearty Deepak
Journal:  J Pharm Bioallied Sci       Date:  2016-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.